Susceptibility of enterococci to daptomycin is dependent upon testing methodology

被引:10
作者
Bryant, Kendall A. [2 ]
Roberts, Amity L. [2 ]
Rupp, Mark E. [1 ]
Anderson, James R. [3 ]
Lyden, Elizabeth R. [3 ]
Fey, Paul D. [1 ,2 ]
Van Schooneveld, Trevor C. [1 ]
机构
[1] Univ Nebraska Med Ctr, Coll Med, Dept Internal Med, Div Infect Dis, Omaha, NE 68198 USA
[2] Univ Nebraska Med Ctr, Coll Med, Dept Pathol & Microbiol, Omaha, NE 68198 USA
[3] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE 68198 USA
关键词
Daptomycin; Susceptibility testing; Enterococcus; RESISTANT STAPHYLOCOCCUS-AUREUS; IN-VITRO ACTIVITY; QUINUPRISTIN-DALFOPRISTIN; DE-NOVO; VANCOMYCIN; INFECTIONS; ETEST; MICS; BACTEREMIA; EXPERIENCE;
D O I
10.1016/j.diagmicrobio.2013.04.019
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An increase in daptomycin nonsusceptible enterococci (DNSE) was noted in our institution (8.3% 2008 to 34.5% 2011) using MicroScan methods which may overestimate DNSE prevalence. DNSE (N = 150) from the clinical laboratory (2008-2011) underwent susceptibility testing using broth microdilution (BMD), Etest, Sensititire, MicroScan prompt (MSP), and MicroScan turbidity (MST) with only 20% of isolates confirmed as nonsusceptible. Categorical and essential agreement were highest with MSP and MST, but both missed the majority of resistant isolates (70% and 87% missed). Etest MIC values were statistically higher, more likely to be nonsusceptible, had the lowest very major error rate (37%), and the highest falsely nonsusceptible rate (22%). Sensititre MIC values were not statistically different from BMD, but missed 57% of DNSE. PFGE analysis did not define a clonal outbreak. These findings suggest that MicroScan methods overestimate nonsusceptibility, and the lack of correlation between methods raises questions regarding which method is most effective at confirming nonsusceptibility. (c) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:497 / 501
页数:5
相关论文
共 31 条
[1]  
[Anonymous], 2007, Clinical microbiology procedures handbook
[2]  
[Anonymous], 2011, SIEM HEALTHC DIAGN 1, P182
[3]  
Becton DaC, BD BBL PROMPT IN SYS
[4]   A potential role for daptomycin in enterococcal infections: what is the evidence? [J].
Canton, Rafael ;
Ruiz-Garbajosa, Patricia ;
Chaves, Ricardo L. ;
Johnson, Alan P. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) :1126-1136
[5]  
Clinical and Laboratory Standards Institute, 2020, Performance Standards for Antimicrobial Susceptibility Testing
[6]  
Eliopoulous GM, 2011, CLIN INFECT DIS, V52, P228
[7]   Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia [J].
Erlandson, Kristine Mace ;
Sun, Junfeng ;
Iwen, Peter C. ;
Rupp, Mark E. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (01) :30-36
[8]   Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media [J].
Fuchs, PC ;
Barry, AL ;
Brown, SD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (04) :557-561
[9]   Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 [J].
Hidron, Alicia I. ;
Edwards, Jonathan R. ;
Patel, Jean ;
Horan, Teresa C. ;
Sievert, Dawn M. ;
Pollock, Daniel A. ;
Fridkin, Scott K. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (11) :996-1011
[10]   Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar [J].
Johnson, AP ;
Mushtaq, S ;
Warner, M ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) :860-862